Prostate Cancer Archives - Page 7 of 7 - Clinical Advisor

Prostate Cancer

Providers emphasized the benefits of testing in 71.4% of the discussions by the cons in only 32%.

Include prostate screening risks

Men should be made aware of the possible harms of prostate cancer screening as well as the benefits, but many don’t appear to be getting that information from their clinician.

Testosterone receptors and prostate cancer

Is all prostate cancer testosterone receptor-positive?—Mike Hutchins, MD, Missoula, Mont. Yes, all prostate cells have androgen receptors. This is the reason prostate cancer will respond to androgen deprivation. What has puzzled urologists for more than 50 years now is the mechanism of resistance to androgen ablation. Much attention has focused on the androgen receptor as…

Dye binds to proteins altered by prostate cancer fo form PSA.

Popular drugs lower PSA levels

Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already controversial cancer screenings by lowering serum levels of prostate-specific antigen (PSA).

Next post in News